Skip to main content

Security report for ocutx.com

Ocular Therapeutix Inc. · Healthcare · N/a

Medium risk. 7 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

64/100

Risk levelMedium

0–100, higher is better. How it is calculated

Ocular Therapeutix Inc. is a biopharmaceutical company specializing in innovative ophthalmic products, particularly targeting retinal diseases such as wet Age-Related Macular Degeneration (AMD). The company is advancing clinical trials for AXPAXLI™, an investigational axitinib hydrogel therapy aimed at reducing treatment burden and improving patient outcomes. The website reflects a professional and consistent brand presence with detailed information for patients, investors, and healthcare professionals. Technically, the site is built on WordPress with Elementor and incorporates modern web technologies and SEO best practices, ensuring good performance and mobile optimization. Security posture is solid with HTTPS and secure forms, though it lacks some advanced security headers and explicit privacy compliance documentation. The absence of WHOIS registration data is a notable concern, but the overall business credibility is supported by clinical trial transparency and investor relations. Strategic recommendations include enhancing privacy and cookie policies, publishing security incident response information, and verifying domain registration details to improve trust and compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
58/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

7 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching ocutx.com

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
57
Security headers
15
Email security
75
DNS health
80
Network security
100
GDPR outside view
58
Average
64

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company positions itself as an innovator in the retinal disease treatment market, focusing on reducing therapeutic burden through sustained-release hydrogel therapies. Its business model centers on drug development, clinical trials, and product commercialization targeting patients with retinal diseases and investors interested in biopharmaceutical advancements. The presence of a dedicated investor relations site and detailed pipeline information indicates a mature business with growth ambitions. The company leverages digital marketing tools and analytics to engage its audience but could improve transparency around privacy and security policies. The lack of visible contact emails and phone numbers suggests a preference for controlled communication channels via contact forms. Overall, Ocular Therapeutix demonstrates a focused market presence with potential for expansion in ophthalmic therapeutics.

Security posture

The website employs HTTPS and secure form inputs, indicating a baseline secure environment. However, it lacks visible security headers such as Content-Security-Policy and X-Frame-Options, which are recommended to mitigate common web vulnerabilities. No exposed sensitive data or vulnerable libraries were detected in the HTML content. The absence of explicit privacy and cookie policies, as well as incident response and vulnerability disclosure information, indicates gaps in compliance and security transparency. The WHOIS data absence raises questions about domain registration legitimacy, which could impact trust. Overall, the security posture is moderate but would benefit from enhanced security headers, documented policies, and domain registration verification to strengthen risk management.

Recommendations

  1. Implement and publish comprehensive privacy and cookie policies with user consent mechanisms to ensure GDPR compliance.
  2. Add security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to improve web security.
  3. Publish a security incident response plan and vulnerability disclosure policy to enhance transparency and preparedness.
  4. Verify and update domain WHOIS registration information to improve legitimacy and trust signals.
  5. Enhance accessibility features and conduct regular security audits to maintain a robust security posture.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Ocular Therapeutix Inc.
Description
Ocular Therapeutix delivering innovative opthalmic products focused on retinal disease treatments including AXPAXLI, an investigational axitinib hydrogel for wet AMD.
Key services
Retinal disease treatment development, Clinical trials, Product commercialization
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Elementor, Yoast SEO, jQuery, GSAP (GreenSock Animation Platform), Google Tag Manager
Frameworks
Elementor
Platforms
WordPress CMS
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
80/100
Good practices seen
  • HTTPS enforced
  • No exposed sensitive data in HTML
  • Use of secure forms with search input

Analytics and tracking

Services
Google Analytics (via Google Tag Manager)
Tracking level
moderate
Privacy practices
basic

Advertising

Marketing tools
Yoast SEO
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with rich content and multimedia
  2. No explicit privacy or cookie policies found
  3. No direct contact emails or phone numbers visible on homepage; contact form present
  4. WHOIS data unavailable, raising domain registration concerns
  5. Use of modern web technologies and SEO best practices
  6. No WAF or blocking detected
  7. No adult or NSFW content
  8. Strong focus on retinal disease treatment and clinical research
Technical notes

Notes

The website is built on WordPress CMS using the Elementor page builder and Yoast SEO plugin, supported by jQuery and GSAP for animations. It uses a CDN (b-cdn.net) for hosting static assets, improving load times and performance. The site is mobile-optimized with responsive design and includes SEO best practices such as meta tags and structured data (JSON-LD). Google Tag Manager is used for analytics and tracking. The technical implementation is modern and well-structured, though performance could be further optimized by reducing animation complexity and improving accessibility compliance. The absence of advanced security headers and incomplete privacy documentation are technical gaps that should be addressed to align with best practices.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with ocutx.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review ocutx.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.